GNH USA

Europe — EMA

Ig Vena (Human Normal Immunoglobulin (Iv))

GNH USA supplies Ig Vena (Human Normal Immunoglobulin), a immunoglobulin therapy for primary immunodeficiency, ITP and Kawasaki disease.

Human Normal Immunoglobulin (Iv)

Request sourcing

1
Pack/s

What is Human Normal Immunoglobulin (Iv)?

Human normal immunoglobulin, the active ingredient in Ig Vena, is an immunoglobulin presented as a solution for injection for intravenous use. It treats primary and secondary immunodeficiency diseases, idiopathic thrombocytopenic purpura, Kawasaki disease, and chronic inflammatory demyelinating polyneuropathy.

GNH USA supplies Ig Vena as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

What is Human Normal Immunoglobulin (Iv) used for?

Ig Vena, a human normal immunoglobulin, provides passive immunity for disorders involving antibody deficiency or immune dysregulation. - Primary immunodeficiency diseases: restores deficient IgG levels to reduce infection frequency. - Secondary immunodeficiency: supplements antibodies in patients with acquired immune deficits, such as after chemotherapy. - Idiopathic thrombocytopenic purpura: modulates immune response to increase platelet count. - Kawasaki disease: reduces inflammation and coronary artery complications in the acute phase. - Chronic inflammatory demyelinating polyneuropathy: attenuates autoimmune attack on peripheral nerves.

What are the side effects of Human Normal Immunoglobulin (Iv)?

Ig Vena may be associated with infusion‑related reactions and other adverse events.

Common Side Effects: - Headache: mild to moderate pain often occurring during or shortly after infusion. - Fever and chills: transient rise in body temperature and shivering. - Nausea: occasional upset stomach or feeling of queasiness. - Fatigue: temporary tiredness following administration.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Thromboembolic events: clot formation that can affect veins or arteries. - Renal failure: impaired kidney function, especially with high infusion volumes. - Aseptic meningitis: inflammation of the meninges without infection.

What precautions apply to Human Normal Immunoglobulin (Iv)?

When using Ig Vena, clinicians should observe several safety measures. - Screen for IgA deficiency: patients with anti‑IgA antibodies may develop severe reactions. - Monitor renal function: high‑volume infusions can stress kidneys. - Assess thrombotic risk: consider prophylaxis in patients with known risk factors. - Avoid use in patients with known hypersensitivity to immunoglobulin products. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Human Normal Immunoglobulin (Iv) interact with?

Ig Vena can interact with several medications; awareness of the level of interaction helps guide monitoring.

Major Interactions (Avoid): - Live vaccines: concurrent use may reduce vaccine efficacy and increase infection risk. - Cytotoxic chemotherapy: may heighten renal toxicity when combined. - Anticoagulants: can potentiate bleeding risk due to volume load.

Moderate Interactions (Monitor Closely): - Diuretics: monitor fluid balance and electrolytes during infusion. - ACE inhibitors: watch for hypotension, especially with rapid infusion rates. - Rituximab: may alter immunoglobulin levels and affect therapeutic response.

Frequently asked questions

What conditions is Ig Vena used to treat?+
Ig Vena is indicated for primary and secondary immunodeficiency diseases, idiopathic thrombocytopenic purpura (ITP), Kawasaki disease, and chronic inflammatory demyelinating polyneuropathy. In each case, the product supplies pooled IgG antibodies to replace deficient immune components or to modulate abnormal immune activity.
How does human normal immunoglobulin work?+
Human normal immunoglobulin provides passive immunity by delivering a broad spectrum of IgG antibodies collected from healthy donors. These antibodies neutralize pathogens, block toxin activity, and interact with immune cell receptors to regulate complement activation and cytokine release, helping restore normal immune function.
What determines the dosing of Ig Vena?+
The dose of Ig Vena is individualized by the prescribing clinician based on the patient’s weight, the specific indication, severity of disease, and clinical response. Dosing regimens may vary from single‑dose infusions to repeated cycles, and the prescriber adjusts the schedule as needed.
Is Ig Vena safe during pregnancy or breastfeeding?+
Safety data for Ig Vena in pregnancy and lactation are limited, and the product’s pregnancy category is not established. Clinicians must weigh potential benefits against unknown risks, and the decision to use Ig Vena should be made on a case‑by‑case basis with specialist input.
How do I order Ig Vena from GNH USA?+
To order Ig Vena, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, cold‑chain shipping details and necessary import documentation.
How does Ig Vena compare with other IVIG products?+
Ig Vena is a EU‑sourced human normal immunoglobulin formulated for intravenous infusion, comparable in composition to other IVIG brands. Differences may lie in manufacturing processes, stabilizers, and concentration, which can affect infusion rates, tolerability and supply chain logistics. Clinical efficacy is generally considered equivalent when dosing is appropriate.
What are the recommended storage conditions for Ig Vena?+
Ig Vena must be stored refrigerated between 2 °C and 8 °C. The product should be kept in its original container, protected from light, and must never be frozen or shaken. If temperature excursions occur, consult the manufacturer’s guidelines before use.
How is Ig Vena administered to patients?+
Ig Vena is given as an intravenous infusion by a qualified healthcare professional. The infusion rate is typically started slowly and may be increased as tolerated. Administration sets and infusion pumps are used to control volume and speed, and patients are monitored for adverse reactions throughout the procedure.
What are the most serious risks associated with Ig Vena?+
The most serious risks include anaphylactic or severe allergic reactions, thromboembolic events, renal impairment or failure, and aseptic meningitis. Prompt recognition and management of these events are essential, and patients should be observed closely during and after infusion.
Who should not receive Ig Vena?+
Ig Vena is contraindicated in individuals with a known hypersensitivity to human immunoglobulin products or any of the excipients. Patients with selective IgA deficiency who have anti‑IgA antibodies are also at high risk for severe reactions and should avoid this therapy.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Human Normal Immunoglobulin (Iv)
Route
Intravenous Use
Manufacturer
Kedrion S.P.A.
Origin
EU

Related products

Flebogamma Dif

Flebogamma Dif

Human Normal Immunoglobulin (Iv)

Instituto Grifols, S.A.
EU
Flebogamma Dif

Flebogamma Dif

Human Normal Immunoglobulin (Iv)

Instituto Grifols, S.A.
EU
Flebogamma Dif

Flebogamma Dif

Human Normal Immunoglobulin (Iv)

Instituto Grifols, S.A.
EU
Gaminex

Gaminex

Human Normal Immunoglobulin (Iv)

Demo Abee
EU